Diabetol Metab Syndr
January 2016
Background: To compare the effects of nateglinide and rosiglitazone on inflammatory markers, GLP-1 levels and metabolic profile in patients with type 2 diabetes (DM2).
Methods: A prospective study was performed in 20 patients with DM2, mean age 51.82 ± 8.